CAR-T cell therapy for triple-negative breast cancer and other solid tumors: preclinical and clinical progress

C Corti, K Venetis, E Sajjadi, L Zattoni… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Most breast cancer-related deaths arise from triple-negative breast cancer
(TNBC). Molecular heterogeneity, aggressiveness and the lack of effective therapies are …

[HTML][HTML] Endometriosis: update of pathophysiology,(epi) genetic and environmental involvement

N Monnin, AJ Fattet, I Koscinski - Biomedicines, 2023 - mdpi.com
Endometriosis is a chronic disease caused by ectopic endometrial tissue. Endometriotic
implants induce inflammation, leading to chronic pain and impaired fertility. Characterized …

Advancement in precision diagnosis and therapeutic for triple-negative breast cancer: Harnessing diagnostic potential of CRISPR-cas & engineered CAR T-cells …

V Nayak, S Patra, KRB Singh, B Ganguly… - Environmental …, 2023 - Elsevier
Cancer is characterized by uncontrolled cell growth, disrupted regulatory pathways, and the
accumulation of genetic mutations. These mutations across different types of cancer lead to …

[HTML][HTML] Breast cancer with bone metastasis: molecular insights and clinical management

K Venetis, R Piciotti, E Sajjadi, M Invernizzi, S Morganti… - Cells, 2021 - mdpi.com
Despite the remarkable advances in the diagnosis and treatment of breast cancer patients,
the presence or development of metastasis remains an incurable condition. Bone is one of …

Precision medicine in breast cancer: From clinical trials to clinical practice

E Crimini, M Repetto, P Aftimos, A Botticelli… - Cancer treatment …, 2021 - Elsevier
Introduction Breast cancer (BC) is the most common cancer in women and, despite the
undeniable improvements in the outcome of these patients obtained in the last decade, the …

[HTML][HTML] Predictive, preventive, and personalized medicine in breast cancer: targeting the PI3K pathway

M Tufail, JJ Hu, J Liang, CY He, WD Wan… - Journal of Translational …, 2024 - Springer
Breast cancer (BC) is a multifaceted disease characterized by distinct molecular subtypes
and varying responses to treatment. In BC, the phosphatidylinositol 3-kinase (PI3K) pathway …

[HTML][HTML] Akt isoforms: a family affair in breast cancer

A Basu, CB Lambring - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the second leading cause of cancer-related death in
women in the United States. The Akt signaling pathway is deregulated in approximately 70 …

Low-risk triple-negative breast cancers: Clinico-pathological and molecular features

N Fusco, E Sajjadi, K Venetis, M Ivanova… - Critical Reviews in …, 2022 - Elsevier
Triple-negative breast cancers (TNBC) comprise biologically and clinically heterogeneous
diseases characterized by the lack of hormone receptors (HR) and HER2 expression. This …

[HTML][HTML] Discordance of PIK3CA mutational status between primary and metastatic breast cancer: a systematic review and meta-analysis

J Rosin, E Svegrup, A Valachis, I Zerdes - Breast Cancer Research and …, 2023 - Springer
Introduction In light of the clinically meaningful results of the PI3K inhibitors in PIK3CA-
mutated metastatic breast cancer (BC) patients, the reliable identification of PIK3CA …

[HTML][HTML] Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterization

E Sajjadi, K Venetis, R Piciotti, M Invernizzi… - Cancer Cell …, 2021 - Springer
The clinical outcome of patients with a diagnosis of hormone receptor (HR)+ breast cancer
has improved remarkably since the arrival of endocrine therapy. Yet, resistance to standard …